Harvard’s AI research uncovers long COVID with precision, revealing 24,000 cases and advancing personalized medicine amidst a global health crisis.
Recent research from Harvard Medical School highlights an innovative AI tool developed by Mass General Brigham to help identify long COVID, also known as post-acute sequelae of COVID-19 (PASC). This method uses electronic health record data to provide precise phenotyping, which improves the detection of long COVID without underestimating its prevalence. The study, involving over ...
